You are currently browsing the tag archive for the 'Capitalism' tag.
With thanks: International Marxist Website
Cross Posted at : Sherryx’s Weblog
We are constantly bombarded with the myth that capitalism drives innovation, technology, and scientific advancement. But in fact, the precise opposite is true. Capitalism is holding back every aspect of human development, and science and technology is no exception.
We are constantly bombarded with the myth that capitalism drives innovation, technology, and scientific advancement. We are told that competition, combined with the profit motive, pushes science to new frontiers and gives big corporations incentive to invent new medicines, drugs, and treatments. The free market, we are told, is the greatest motivator for human advance. But in fact, the precise opposite is true. Patents, profits, and private ownership of the means of production are actually the greatest fetters science has known in recent history. Capitalism is holding back every aspect of human development, and science and technology is no exception.
Main slab of the Darwinius masillae holotype fossil. Photo by Jens L. Franzen, Philip D. Gingerich, Jörg Habersetzer1, Jørn H. Hurum, Wighart von Koenigswald, B. Holly Smith.The most recent and blatant example of private ownership serving as a barrier to advancement can be found in the Ida fossil. Darwinius masillae is a 47 million year old lemur that was recently “discovered”. Anyone and everyone interested in evolution cheered at the unveiling of a transitional species, linking upper primates and lower mammals. Ida has forward-facing eyes, short limbs, and even opposable thumbs. What is even more remarkable is the stunning condition she was preserved in. This fossil is 95% complete. The outline of her fur is clearly visible and scientists have even been able to examine the contents of her stomach, determining that her last meal consisted of fruits, seeds, and leaves. Enthusiasts are flocking to New York’s Museum of Natural History to get a glimpse of the landmark fossil.
So what does Ida have to do with capitalism? Well, she was actually unearthed in 1983 and has been held by a private collector ever since. The collector didn’t realize the significance of the fossil (not surprising since he is not a paleontologist) and so it just collected dust for 25 years.
There is a large international market for fossils. Capitalism has reduced these treasures, which rightly belong to all of humanity, to mere commodities. Privately held fossils are regularly leased to museums so that they may be studied or displayed. Private fossil collections tour the world, where they can make money for their owners, instead of undergoing serious study. And countless rare specimens sit in the warehouses of investment companies, or the living rooms of collectors serving as nothing more than a conversation piece. It is impossible to know how many important fossils are sitting, waiting to be discovered in some millionaire’s office.
Medical Research
The pharmaceutical industry is well known for price gouging and refusing to distribute medicines to those who can’t afford it. The lack of drugs to combat the AIDS pandemic, particularly in Africa, is enough to prove capitalism’s inability to distribute medicine to those in need. But what role does the profit motive play in developing new drugs? The big pharmaceuticals have an equally damning record in the research and development side of their industry.
AIDS patients can pay tens of thousands of dollars per year for the medication they need to keep them alive. In 2003, when a new drug called Fuzeon was introduced, there was an outcry over the cost, which would hit patients with a bill of over $20,000 per year. Roche’s chairman and chief executive, Franz Humer tried to justify the price tag, “We need to make a decent rate of return on our innovations. This is a major breakthrough therapy… I can’t imagine a society that doesn’t want that innovation to continue.”
But the innovation that Mr. Humer speaks of is only half-hearted. Drug companies are not motivated by compassion; they are motivated by cash. To a drug company, a person with AIDS is not a patient, but a customer. The pharmaceutical industry has a financial incentive to make sure that these people are repeat-customers, consequently there is very little research being done to find a cure. Most research done by the private sector is centered on finding new anti-retroviral drugs – drugs that patients will have to continue taking for a lifetime.
There has been a push to fund research for an AIDS vaccine and, more recently, an effective microbicide. However, the vast majority of this funding comes from government and non-profit groups. The pharmaceutical industry simply isn’t funding the research to tackle this pandemic. And why would they? No company on earth would fund research that is specifically designed to put them out of business.
Jeremy Harding [with thanks: LRB]
Last September, as dust and debris from the tellers’ floors began raining onto the empty vaults below, a note of satisfaction was sounded by bankers in the Arab world. Financial institutions sticking to the tenets of Islam, they announced, were largely immune from the debt crisis. Devout Muslims may lend and borrow under certain conditions; they can even buy and sell debt in the form of ‘Islamic’ bonds, but most other kinds of debt trading are frowned on. Al Rajhi Bank, based in Saudi Arabia, and the Kuwait Finance House posted impressive profits in 2008. Both have come under some nervous scrutiny in 2009 but their ability to weather the recession that has set in behind the credit crunch is not at issue.
Unlike most banks in the Middle East, Al Rajhi Bank and KFH are ‘sharia-compliant’ businesses, which means simply that they try to abide by the evolving body of rules known as the sharia – ‘the path to the headwater’ – which govern the lives of Muslims. The sharia serves mostly as a guide to personal conduct, though some rules are drafted into the legal codes of majority-Muslim states. It’s founded, we’re always told, on revealed truth from the Koran and exemplary stories from the Hadith, the sayings and doings of the Prophet. But the real influence of the sharia lies in the way this material is constantly read and recast by modern Islamic scholars, reinventing old traditions or asserting new ones. Whatever they take it to be, growing numbers of Muslims are keen to stay on the path when it comes to banking and finance. The global Muslim population is upwards of 1.3 billion – roughly one in every five people on earth – and, with a religious revival of twenty or thirty years’ standing, the way of Islam is now a crowded thoroughfare. It is plied by a great diversity of travellers from different parts of the world; some have money to burn, others next to none, but anybody with a modicum of wealth is nowadays a potential opportunity for banks offering sharia-compliant retail services: current accounts, straightforward financing schemes and home-ownership plans.
The term ‘Islamic finance’ wrests a lot of activities down to a catch-all definition. The same is true, in the financial universe, of the words ‘sharia’ and ‘Islam’ itself. Sharia is not a single, coherent jurisprudence for Muslims; there are various schools of interpretation and marked disagreements within each of them. ‘Islam’, a broad term of convenience for most non-Muslims, is a power-point word in the City: it tells bankers and traders that every day for a few minutes they should shut out the din of the money that merely talks and tune in to the money that prays. But why bother, given that sharia-compliant finance is probably worth less than 1 per cent of the total value of the world’s stocks, bonds and bank deposits? This was reckoned at about $170 trillion in 2007; it’s much less than that now of course, but even so, with a value of around $700 billion, Islamic stocks, bonds and bank deposits remain a minority affair, just as Muslims remain a minority in global terms.


Recent Comments